Kelly JS - Search Results

1

In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.

Fairbrother IS, Arbuthnott GW, Kelly JS, Butcher SP. Fairbrother IS, et al. Among authors: kelly js. J Neurochem. 1990 Jun;54(6):1834-43. doi: 10.1111/j.1471-4159.1990.tb04880.x. J Neurochem. 1990. PMID: 2338544

2

In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion.

Butcher SP, Varro A, Kelly JS, Dockray GJ. Butcher SP, et al. Among authors: kelly js. Brain Res. 1989 Dec 25;505(1):119-22. doi: 10.1016/0006-8993(89)90121-2. Brain Res. 1989. PMID: 2611663

3

Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.

Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW. Butcher SP, et al. Among authors: kelly js. J Neurochem. 1990 Sep;55(3):981-8. doi: 10.1111/j.1471-4159.1990.tb04587.x. J Neurochem. 1990. PMID: 2117053

4

In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.

Fairbrother IS, Arbuthnott GW, Kelly JS, Butcher SP. Fairbrother IS, et al. Among authors: kelly js. J Neurochem. 1990 Jun;54(6):1844-51. doi: 10.1111/j.1471-4159.1990.tb04881.x. J Neurochem. 1990. PMID: 2338545

5

Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.

Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW. Butcher SP, et al. Among authors: kelly js. J Neurochem. 1988 Feb;50(2):346-55. doi: 10.1111/j.1471-4159.1988.tb02919.x. J Neurochem. 1988. PMID: 2447237

6

Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801.

Sharkey J, Butcher SP, Kelly JS. Sharkey J, et al. Among authors: kelly js. J Auton Nerv Syst. 1994 Sep;49 Suppl:S177-85. doi: 10.1016/0165-1838(94)90109-0. J Auton Nerv Syst. 1994. PMID: 7836677

7

Binding of 5-HT1A receptor and 5-HT transporter ligands in rat cortex and hippocampus following cholinergic and serotonergic lesions.

Lawrence JA, Olverman HJ, Shirakawa K, Kelly JS, Butcher SP. Lawrence JA, et al. Among authors: kelly js. Brain Res. 1993 May 28;612(1-2):326-9. doi: 10.1016/0006-8993(93)91680-q. Brain Res. 1993. PMID: 7687192

8

Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist.

Hodgkiss JP, Sherriffs HJ, Cottrell DA, Shirakawa K, Kelly JS, Kuno A, Ohkubo M, Butcher SP, Olverman HJ. Hodgkiss JP, et al. Among authors: kelly js. Eur J Pharmacol. 1993 Aug 24;240(2-3):219-27. doi: 10.1016/0014-2999(93)90902-t. Eur J Pharmacol. 1993. PMID: 7902282

9

Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.

Sharkey J, Ritchie IM, Butcher SP, Kelly JS. Sharkey J, et al. Among authors: kelly js. Brain Res. 1994 Jul 18;651(1-2):27-36. doi: 10.1016/0006-8993(94)90677-7. Brain Res. 1994. PMID: 7922575

10

Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.

Sharkey J, Ritchie IM, Butcher SP, Kelly JS. Sharkey J, et al. Among authors: kelly js. Brain Res. 1996 Sep 30;735(1):67-82. doi: 10.1016/0006-8993(96)00574-4. Brain Res. 1996. PMID: 8905171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters